November 27, 2018

Fresh funds to fuel the fight against drug-resistant bacteria

BioVersys together with BioSystems Technology and Voxcan announced funding - € 840,000 over a 3-year period - by Eurostars for IMPACT2, a new translational AMR platform that will expedite the development of novel new medicines in the fight against antimicrobial resistance.

Interview here

http://c1940652.r52.cf0.rackcdn.com/58528159b8d39a3eff000d0c/news1.jpg